UBS analyst Michael Cherny reiterates Buy rating and raises price target on CVS Health Corp. (NYSE: CVS) to $89 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE